feed,title,long_url,short_url
Benzinga,Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics,https://benzinga.com/analyst-ratings/analyst-color/23/06/33082668/genuine-monotherapy-approach-in-egfrm-nsclc-analyst-upgrades-switches-to-buy-on-bla,https://da.gd/Aa7jD
